GIUSTINA, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 22.181
AS - Asia 9.518
EU - Europa 7.553
SA - Sud America 1.670
AF - Africa 198
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 22
Totale 41.165
Nazione #
US - Stati Uniti d'America 21.965
CN - Cina 3.509
SG - Singapore 3.127
UA - Ucraina 2.589
BR - Brasile 1.385
HK - Hong Kong 1.195
DE - Germania 1.059
PL - Polonia 775
FR - Francia 715
FI - Finlandia 622
VN - Vietnam 534
GB - Regno Unito 452
TR - Turchia 375
IE - Irlanda 372
RU - Federazione Russa 363
IT - Italia 354
IN - India 292
CA - Canada 118
BD - Bangladesh 116
AR - Argentina 90
ZA - Sudafrica 68
MX - Messico 62
IQ - Iraq 60
SE - Svezia 54
EC - Ecuador 50
ID - Indonesia 41
NG - Nigeria 37
ES - Italia 35
PY - Paraguay 35
SA - Arabia Saudita 34
PK - Pakistan 33
NL - Olanda 32
JP - Giappone 31
CO - Colombia 28
MA - Marocco 28
BE - Belgio 27
CZ - Repubblica Ceca 27
CL - Cile 25
IR - Iran 25
VE - Venezuela 24
UZ - Uzbekistan 23
AU - Australia 21
EU - Europa 20
PE - Perù 20
AE - Emirati Arabi Uniti 19
AT - Austria 17
NP - Nepal 14
KE - Kenya 13
JO - Giordania 12
AZ - Azerbaigian 11
JM - Giamaica 11
DZ - Algeria 8
ET - Etiopia 8
IL - Israele 8
KZ - Kazakistan 8
LT - Lituania 8
PT - Portogallo 8
TN - Tunisia 8
UY - Uruguay 7
EG - Egitto 6
HN - Honduras 6
KR - Corea 6
OM - Oman 6
BO - Bolivia 5
MU - Mauritius 5
MY - Malesia 5
PH - Filippine 5
RO - Romania 5
AL - Albania 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
EE - Estonia 4
LV - Lettonia 4
PA - Panama 4
TH - Thailandia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CH - Svizzera 3
CM - Camerun 3
DK - Danimarca 3
GE - Georgia 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
AM - Armenia 2
BB - Barbados 2
BW - Botswana 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
MN - Mongolia 2
NO - Norvegia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
Totale 41.145
Città #
Fairfield 3.211
Woodbridge 2.446
Ashburn 1.957
Houston 1.752
Jacksonville 1.741
Singapore 1.665
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.222
Hong Kong 1.186
Wilmington 1.112
Warsaw 771
Princeton 689
Nanjing 637
Beijing 631
The Dalles 625
Chandler 515
San Jose 480
Dublin 370
New York 309
Lauterbourg 303
Istanbul 298
Helsinki 266
Nanchang 256
Los Angeles 239
Moscow 201
Des Moines 187
Ho Chi Minh City 184
Shenyang 167
Buffalo 156
Changsha 142
San Diego 131
Hebei 127
São Paulo 119
Hanoi 116
Tianjin 116
Jiaxing 112
Milan 104
Redondo Beach 104
Munich 80
Shanghai 75
Kunming 72
Chicago 71
Jinan 68
Brescia 59
San Francisco 59
Dallas 57
Orem 55
Hangzhou 50
Council Bluffs 49
Dearborn 49
Verona 47
Lancaster 44
London 44
Rio de Janeiro 42
Santa Clara 40
Toronto 38
Abuja 37
Lanzhou 37
San Mateo 37
Johannesburg 35
Kocaeli 35
Chennai 34
Haikou 33
Brooklyn 32
Guangzhou 32
Zhengzhou 32
Montreal 31
Tokyo 31
Turku 30
Belo Horizonte 29
Ningbo 29
Atlanta 28
Boardman 28
Dong Ket 28
Leawood 28
Manchester 28
Mexico City 28
Dhaka 27
Brussels 24
Poplar 24
Augusta 23
Denver 22
Phoenix 22
Porto Alegre 22
Taizhou 22
Brasília 21
Curitiba 21
Quito 21
Brno 20
Stockholm 20
Da Nang 19
Mumbai 19
Tashkent 19
Ankara 18
Ardabil 18
Changchun 18
Baghdad 17
Biên Hòa 17
Boston 17
Totale 29.344
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 348
Elevated intraocular pressure in patients with acromegaly 338
Ghrelin regulates proliferation and differentiation of osteoblastic cells 263
Guidelines for acromegaly management. 226
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 222
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 196
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 193
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 192
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 192
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 189
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 186
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 183
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 181
Growth hormone deficiency in treated acromegaly 181
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 181
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 176
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 173
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 171
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 167
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 165
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 164
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 162
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 161
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 156
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 155
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 154
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 152
A consensus on criteria for cure of acromegaly. 152
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 152
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 151
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 150
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 149
The management of the patient with acromegaly and headache: a still open clinical challenge. 148
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 148
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 148
Diagnosis and treatment of acromegaly complications. 146
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 146
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 145
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 144
Cardiovascular risk in aging and obesity: is there a role for GH. 144
Guidelines for acromegaly management: an update. 143
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 143
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 143
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 143
High prevalence of radiological vertebral fractures in HIV-infected males 143
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 143
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 143
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 142
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 142
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 142
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 141
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 140
Growth hormone deficiency in the adult. 140
Acromegalic patients show the presence of hypertrophic remodelling of subcutaneous small resistance arteries 140
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 139
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 139
Ambulatory blood pressure monitoring (ABPM) in normotensive patients with acromegaly effect of 24-h continous infusion of octreotide. 139
Prevalence of vertebral fractures in men with acromegaly 138
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 138
A consensus on criteria for cure acromegaly 138
Expert consensus document:A consensus on the medical treatment of acromegaly 138
Octreotide for acromegaly treatment: a reappraisal. 138
Pituitary testing: a reappraisal. 138
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 137
New understanding and treatments for osteoporosis. 136
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 136
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 136
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 136
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 135
Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. 135
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. 134
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 134
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. 134
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 134
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 134
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 133
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 133
New oral anticoagulants and pituitary apoplexy 133
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 133
Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH-an update. 133
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 132
Glucocorticoids and the regulation of growth hormone secretion. 132
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 132
Growth hormone in glucocorticoid-induced osteoporosis. 131
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 131
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 131
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 131
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 130
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 130
Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study. 129
Hypertrophic remodeling of subcutaneous small resistance arteries in acromegalic patients 129
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 129
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 129
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 128
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 128
Current guidelines for adult GH replacement. 127
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 127
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. 127
Glucocorticoids and bone: cellular, metabolic and endocrine effects. 126
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: in vitro studies. 126
Totale 15.254
Categoria #
all - tutte 181.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.335 0 0 0 0 0 0 0 0 0 519 643 173
2021/20222.426 136 492 35 109 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20254.411 15 14 18 605 577 376 316 97 531 262 1.003 597
2025/20268.462 991 1.283 686 1.460 874 534 1.405 302 458 469 0 0
Totale 41.447